Date published:
April 23, 2019

Breakthrough in the attempt to miniaturize the Sencell Glucose Sensor

Lifecare is developing an implantable continuous glucose sensor based on its proprietary osmotic pressure cell technology.

One core element of the glucose sensor is a pressure transducer, which translates the glucose-induced osmotic pressure change in the measurement chamber into a transmittable electronic signal. Until now, the size of the pressure transducer prevented further miniaturization of the osmotic pressure chamber and of the final device.

Other publications

Date published:
September 14, 2020

Lifecares Joint Venture partner Digital Diagnostics AG select WISeKey to secure the CantisenseTM SARS-CoV-2 rapid test

Read more
Date published:
August 25, 2020

Corona antigen rapid test approved for clinical study

Read more
Date published:
June 15, 2020

Lifecare’s partner Digital Diagnostics AG seeks additional approval in Germany for corona virus rapid test

Read more